194 related articles for article (PubMed ID: 23042095)
61. Methylation as a biomarker for head and neck cancer.
Arantes LM; de Carvalho AC; Melendez ME; Carvalho AL; Goloni-Bertollo EM
Oral Oncol; 2014 Jun; 50(6):587-92. PubMed ID: 24656975
[TBL] [Abstract][Full Text] [Related]
62. Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma.
Fung SYH; Chan KCA; Wong EWY; Ng CWK; Cho R; Yeung ZWC; Lam JWK; Chan JYK
Head Neck; 2021 Jun; 43(6):1812-1822. PubMed ID: 33594807
[TBL] [Abstract][Full Text] [Related]
63. Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
Sailer V; Charpentier A; Dietrich J; Vogt TJ; Franzen A; Bootz F; Dietrich D; Schroeck A
PLoS One; 2018; 13(2):e0192742. PubMed ID: 29425237
[TBL] [Abstract][Full Text] [Related]
64. Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma.
Alsofyani AA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Elaimi A; Al-Qahtani MH; Abuzenadah AM; Dallol A
J Appl Genet; 2017 Nov; 58(4):459-465. PubMed ID: 28812223
[TBL] [Abstract][Full Text] [Related]
65. Promoter Hypermethylation of Tumor-Suppressor Genes
Liyanage C; Wathupola A; Muraleetharan S; Perera K; Punyadeera C; Udagama P
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013839
[TBL] [Abstract][Full Text] [Related]
66. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.
Schussel J; Zhou XC; Zhang Z; Pattani K; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Brait M; Li R; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
Clin Cancer Res; 2013 Jun; 19(12):3268-75. PubMed ID: 23637120
[TBL] [Abstract][Full Text] [Related]
67. Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma.
Marsit CJ; Posner MR; McClean MD; Kelsey KT
Cancer; 2008 Oct; 113(7):1566-71. PubMed ID: 18711702
[TBL] [Abstract][Full Text] [Related]
68. Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer.
Worsham MJ; Chen KM; Stephen JK; Havard S; Benninger MS
Otolaryngol Head Neck Surg; 2010 Jul; 143(1):116-21, 121.e1-19. PubMed ID: 20620629
[TBL] [Abstract][Full Text] [Related]
69. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
[TBL] [Abstract][Full Text] [Related]
70. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.
Lim Y; Sun CX; Tran P; Punyadeera C
Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346
[TBL] [Abstract][Full Text] [Related]
71. Identification of guanine nucleotide-binding protein γ-7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling.
Demokan S; Chuang AY; Chang X; Khan T; Smith IM; Pattani KM; Dasgupta S; Begum S; Khan Z; Liegeois NJ; Westra WH; Sidransky D; Koch W; Califano JA
Int J Oncol; 2013 Apr; 42(4):1427-36. PubMed ID: 23403885
[TBL] [Abstract][Full Text] [Related]
72. The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck.
Lee CC; Lee MS; Ho HC; Hung SK; Tung YT; Chou P; Su YC
Clin Chem Lab Med; 2009; 47(10):1277-83. PubMed ID: 19743954
[TBL] [Abstract][Full Text] [Related]
73. Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer.
Misawa K; Kanazawa T; Misawa Y; Imai A; Uehara T; Mochizuki D; Endo S; Takahashi G; Mineta H
J Cancer Res Clin Oncol; 2013 May; 139(5):879-89. PubMed ID: 23420374
[TBL] [Abstract][Full Text] [Related]
74. MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index.
Langevin SM; Stone RA; Bunker CH; Grandis JR; Sobol RW; Taioli E
Carcinogenesis; 2010 May; 31(5):864-70. PubMed ID: 20197299
[TBL] [Abstract][Full Text] [Related]
75. Serum biomarkers for detection of head and neck squamous cell carcinoma.
Mydlarz WK; Hennessey PT; Wang H; Carvalho AL; Califano JA
Head Neck; 2016 Jan; 38(1):9-14. PubMed ID: 24995714
[TBL] [Abstract][Full Text] [Related]
76. The gene expression profile of inflammatory, hypoxic and metabolic genes predicts the metastatic spread of human head and neck squamous cell carcinoma.
Clatot F; Gouérant S; Mareschal S; Cornic M; Berghian A; Choussy O; El Ouakif F; François A; Bénard M; Ruminy P; Picquenot JM; Jardin F
Oral Oncol; 2014 Mar; 50(3):200-7. PubMed ID: 24387976
[TBL] [Abstract][Full Text] [Related]
77. Salivary DNA methylation markers for cancer of oral cavity.
Kabekkodu SP; Chakrabarty S; Varghese VK; Ghosh S; Radhakrishnan R; Mallya SP; Kudva A
Cancer Biomark; 2022; 35(3):257-268. PubMed ID: 36245370
[TBL] [Abstract][Full Text] [Related]
78. The neuropeptide genes
Misawa K; Mima M; Imai A; Mochizuki D; Misawa Y; Endo S; Ishikawa R; Kanazawa T; Mineta H
Clin Epigenetics; 2018; 10():52. PubMed ID: 29682090
[TBL] [Abstract][Full Text] [Related]
79. Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression.
Kornfeld JW; Meder S; Wohlberg M; Friedrich RE; Rau T; Riethdorf L; Löning T; Pantel K; Riethdorf S
Br J Cancer; 2011 Jan; 104(1):138-45. PubMed ID: 21102583
[TBL] [Abstract][Full Text] [Related]
80. Gene promoter hypermethylation in oral rinses of leukoplakia patients--a diagnostic and/or prognostic tool?
López M; Aguirre JM; Cuevas N; Anzola M; Videgain J; Aguirregaviria J; Martínez de Pancorbo M
Eur J Cancer; 2003 Nov; 39(16):2306-9. PubMed ID: 14556921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
